Медицинская литература. Новинки

 

 

 

 

 

 

ЦИТОКИНОПОСРЕДОВАННЫЕ МЕХАНИЗМЫ ФОРМИРОВАНИЯ АУТОИММУННЫХ ТИРЕОПАТИЙ

Вы можете загрузить полный текст статьи в формате pdf

Обзор посвящен современным представлениям о роли цитокинов в формировании аутоиммунных тиреопатий.

Ключевые слова:
аутоиммунный тиреоидит, болезнь Грейвса, цитокины, иммунопатогенез.

Литература:
1. Белушкина Н.Н. Молекулярные основы патологии апоптоза /
Н.Н. Белушкина, С.Е. Северин // Арх. патол. 2001. №1.
С. 51–60.
2. Дрометр Д.А. и др. Иммунологические аспекты дифференциальной диагностики синдрома гипертиреоза // Клин. и экспер. тиреоидол. 2007. Т. 3. №1. С. 18–23.
3. Кандрор В.И. Механизмы развития болезни Грейвса и
действия тиреоидных гормонов // Клин. и экспер. тиреоидол. 2008. Т. 4. №1. С. 26–34.
4. Кандрор В.И. Эндокринология. М.: Практика, 1999.
5. Лебедев К.А., Понякина И.Д. Иммунная недостаточность (выявление и лечение). М.: Медкнига, 2003.
6. Пальцев М.А., Иванов А.А., Северин С.Е. Межклеточные взаимодействия. М.: Медицина, 2003.
7. Сарвилина И.В. Междисциплинарные исследования в медицине / Сарвилина И.В., Каркищенко В.Н., Горшкова Ю.В.
М.: Техносфера, 2007. С. 112–122.
8. Фадеев В.В., Мельниченко Г.А., Герасимов Г.А. // Проб. эндокринол. 2001. Т. 47. №4. С. 7–13.
9. Arpin C., Pihlgren M., Fraichard A. et al. Effects of T3Ra1 and
T3Ra2 Gene Deletion on T and B lymphocyte Development //
J. Immunol. 2000. V. 164. P. 152–160.
10. Botella#Carretero J., Prados A., Manzano L. et al. The effects of
thyroid hormones on circulating markers of cellmediated immune
response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal // Eur. J. Endocrinol.
2005. V. 153. P. 223–230.
11. Bretz J.D., Baker J.R. Apoptosis and autoimmune thyroid disease:
following a TRAIL to thyroid destruction? // Clin. Endocrinol.
2001. V. 55. N1. P. 1–11.
12. Bretz J.D., Rymaszeweski M. TRAIL death pathway expression and
induction in thyroid follicular cells // J. Biolog. Chemistr. 1999.
V. 274. P. 23627–23632.
13. Caturegli P., Mariotti S., Kuppers R.C. et al. Epitopes on thyroglobulin: a study of patients with thyroid disease //
Autoimmunit. 1994. V. 18. P. 4149.
14. Fang Y., Braley#Mullen H. Cultured Murine Thyroid Epithelial
Cells Expressing Transgenic FasAssociated Death Domain-Like
Interleukin1Converting Enzyme Inhibitory Protein Are
Protected from FasMediated Apoptosis // Endocrinol. 2008.
V. 48. P. 3321–3329.
15. Fang Y., Sharp G.C., Braley#Mullen H. Interleukin-10 Promotes
Resolution of Granulomatous Experimental Autoimmune
Thyroiditis // Am. J. Pathol. 2008. V. 172. N6. P. 1591–1602.
16. Giordano C., Stassi G., De Maria R. et al. Potential involvement of
Fas and its ligand in the pathogenesis of Hashimotos thyroiditis //
Science. 1997. V. 275. P. 960963.
17. Jiskra J., Antošová M., Límanová Z. et al. The relationship
between thyroid function, serum monokine induced by interferon
gamma and soluble interleukin2 receptor in thyroid autoimmune
diseases // Clin. Experiment. Immunol. 2009. V. 156. P. 211–216.
18. Kawakami A., Eguchi K., Matsuoka N. et al. Thyroid-stimulating
hormone inhibits Fas antigenmediated apoptosis of human thyrocytes in vitro // Endocrinol. 1996. V. 137. P. 3163–3169.
19. Kayagaki N., Yamaguchi N., Nakayama M. et al. Involvement of
TNFrelated apoptosisinducing in human CD41 T-cell-mediated
cytotoxicity // J. Immunol. 1999. V. 162. P. 2639–2647.
20. Mariani S.M., Krammer P.H. Surface expression of TRAIL/Apo2 ligand in activated mouse T and B cells // Eur. J. Immunol. 1998.
V. 28. P. 1492–1498.
21. Marino M., Chiovato L., Friedlander J.A. et al. Serum antibodies
against megalin (GP330) in patients with autoimmune thyroiditis // J. Clin. Endocrinol. Metab. 1999. V. 84. P. 2468–2474.
22. Marino M., Zheng G., Chiovato L. et al. Role of megalin (gp330) in
transcytosis of thyroglobulin by thyroid cells: a novel function in
the control of thyroid hormone release // J. Biol. Chem. 2000.
V. 275. P. 7125–7138.
23. Mariotti S., Caturegli P., Piccolo P. et al. Antythyroid peroxidase
antibodies in thyroid diseases // J. Clin. Edocrinol. Metab. 1990.
V. 71. P. 661–669.
24. Mascanfroni I., Montesinos M., Susperreguy S., Cervi et al. Control
of dendritic cell maturation and function by triiodothyronine //
FASEB J. 2008. V. 22. P. 1032–1042.
25. McLachlan S.M., Rapoport B. The molecular biology of thyroid
peroxidase: Cloning, expression, and role as autoantigen in
autoimmune thyroid disease // Endocr. Rev. 1992. V. 13.
P. 192–206.
26. Nakahara M., Nagayama Y., Saitoh O. et al. Expression of Immunoregulatory Molecules by Thyrocytes Protects Nonobese
DiabeticH2h4 Mice from Developing Autoimmune Thyroiditis //
Endocrinol. 2009. V. 150. P. 1545–1551.
27. Neves S.R., Ram P.T., Iyengar R. Gprotein pathways // Science.
2002. V. 296. P. 1636–1639.
28. Paolieri F., Salmaso C. Possible pathogenetic relevance of interleukin-1 beta in “destructive” organspecific autoimmune disease
(Hashimoto's thyroiditis) // Ann. N.Y. Acad. Sci. 1999. V. 22.
N876. P. 221–228.
29. Phenekos C. Th1 and Th2 serum cytokine profiles characterize
patients with Hashimotos thyroiditis (Th1) and Graves disease
(Th2) // Neuroimmunomodul. 2004. V. 11. P. 209–213.
30. Poncin S., Lengele B., Colin I.M. et al. Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the
Regulation of Thyroperoxidase and Dual Oxidase Expression,
and of Thyroglobulin Secretion in Thyrocytes in Vitro //
Endocrinol. 2008. V. 149. P. 1534–1542.
31. Solerte S.B. Defect of a subpopulation of natural killer immune
cells in Graves disease and Hashimotos thyroiditis: normalizing
effect of dehydroepiandrosterone sulfate // Eur. J. Endocrinol.
2005. V. 152. P. 703–712.
32. Spitzweg C., Heufelder A.E. Update on the thyroid sodium iodide
symporter: a novel thyroid antigen emerging on the horizon // Eur.
J. Endocrinol. 1997. V. 137. P. 22–23.
33. Tang H., Meroni P.L. The effects of a monoclonal antibody to
interferongamma on experimental autoimmune thyroiditis
(EAT): prevention of disease and decrease of EATspecific T
cells // Eur. J. Immunol. 1993. V. 23. P. 275–278.
34. Vassart G., Dumont J.E. The thyrotropin receptor and the regulation of thyroid function and growth // Endocr. Rev. 1992. V. 13.
P. 596–611.
35. Volpe R. The pathology of thyroiditis // Hum. Pathol. 1978. V. 9.
P. 429–438.
36. Weetman A.P., Ajjan R.A. Cytokines and autoimmune thyroid
diease // HOT THYROIDOLOGY (www.hotthyroidology.com).
2002. N1.
37. Wendling U. Expression of TRAIL receptors in human autoreactive
and foreign antigenspecific T cells // Cell. Death. Differentiat.
2000. V. 7. P. 637–644.
38. Yanagisawa J., Takahashi M., Kanki H. et al. The molecular interaction of Fas and FAP1: a tripeptide blocker of human Fas interaction with FAP1 promotes Fasinduced apoptosis // J. Biol.
Chem. 1997. V. 272. P. 8539–8545.
39. Zamai L. Natural killer (NK) cellmediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells // J. Exper. Med. 1998. V. 188. P. 2375–2380.

Cytokine-dependent mechanisms in development of autoimmune thyroid disorders

This review of literature discusses impact of cytokine regulation in pathogenesis of autoimmune thyroiditis and Graves's disease

Keywords:
autoimmune thyroiditis, Graves's disease, cytokines, immune pathogenesis.